Construction of an HLA Classifier for Early Diagnosis, Prognosis, and Recognition of Immunosuppression in Sepsis by Multiple Transcriptome Datasets

Construction of an HLA Classifier for Early Diagnosis, Prognosis, and Recognition of Immunosuppression in Sepsis by Multiple Transcriptome Datasets

Background: Sepsis is a clinical syndrome, due to a dysregulated inflammatory response to infection. Accumulating evidence shows that human leukocyte antigen (HLA) genes play a key role in the immune responses to sepsis. Nevertheless, the effects of HLA genes in sepsis have still not been comprehens...

Bibliográfalaš dieđut
Váldodahkkit:	Zhen Chen, Rui Chen, Yangpeng Ou, Jianhai Lu, Qianhua Jiang, Genglong Liu, Liping Wang, Yayun Liu, Zhujiang Zhou, Ben Yang, Liuer Zuo
Materiálatiipa:	Artihkal
Giella:	English
Almmustuhtton:	Frontiers Media S.A. 2022-05-01
Ráidu:	Frontiers in Physiology
Fáttát:	sepsis HLA genes immune infiltration immunosuppression model
Liŋkkat:	https://www.frontiersin.org/articles/10.3389/fphys.2022.870657/full

Geahča maid

Advancing our understanding of monocyte HLA-DR, S100A9, and the potential for individualized therapies in sepsis
Dahkki: Guillaume Monneret
Almmustuhtton: (2023-06-01)

Multi-Omics Endotypes in ICU Sepsis-Induced Immunosuppression
Dahkki: Alexis Garduno, et al.
Almmustuhtton: (2023-04-01)

Single-cell transcriptome profiling of sepsis identifies HLA-DR low S100A high monocytes with immunosuppressive function
Dahkki: Ren-Qi Yao, et al.
Almmustuhtton: (2023-06-01)

Advances in the Study of Immunosuppressive Mechanisms in Sepsis
Dahkki: Fu X, et al.
Almmustuhtton: (2023-09-01)

The choice of immunosuppressive therapy depending on the level of anti-HLA antibodies in kidney transplantation
Dahkki: N. V. Borovkova, et al.
Almmustuhtton: (2018-03-01)

Clinical characteristics, risk factors, immune status and prognosis of secondary infection of sepsis: a retrospective observational study
Dahkki: Yao Chen, et al.
Almmustuhtton: (2019-10-01)

Immunosuppression in sepsis and possibility of its correction
Dahkki: M. V. Kiselevskii, et al.
Almmustuhtton: (2018-10-01)

Clinical practice of sepsis-induced immunosuppression: Current immunotherapy and future options
Dahkki: Fei Pei, et al.
Almmustuhtton: (2024-03-01)

Tim-3 pathway dysregulation and targeting in sepsis-induced immunosuppression
Dahkki: Jialiu Luo, et al.
Almmustuhtton: (2024-12-01)

Immune Dysfunction is Associated with Readmission in Survivors of Sepsis Following Infected Pancreatic Necrosis
Dahkki: Yin J, et al.
Almmustuhtton: (2021-10-01)

Enhanced effect of the immunosuppressive soluble HLA-G2 homodimer by site-specific PEGylation
Dahkki: Chisato Yamada, et al.
Almmustuhtton: (2025-01-01)

Early Prediction for Persistent Inflammation-Immunosuppression Catabolism Syndrome in Surgical Sepsis Patients
Dahkki: Zhong M, et al.
Almmustuhtton: (2021-09-01)

Autophagy: A Potential Therapeutic Target for Reversing Sepsis-Induced Immunosuppression
Dahkki: Chao Ren, et al.
Almmustuhtton: (2017-12-01)

Sepsis-induced immunosuppression: mechanisms, diagnosis and current treatment options
Dahkki: Di Liu, et al.
Almmustuhtton: (2022-10-01)

Expert consensus on the monitoring and treatment of sepsis-induced immunosuppression
Dahkki: Fei Pei, et al.
Almmustuhtton: (2022-12-01)

Understanding sepsis-induced immunosuppression and organ dysfunctions: from immunosuppression to immunotherapy
Dahkki: Dablu Lal Gupta, et al.
Almmustuhtton: (2022-08-01)

Decreased Monocyte HLA-DR Expression in Patients with Sepsis and Acute Kidney Injury
Dahkki: Huang-Pin Wu, et al.
Almmustuhtton: (2022-09-01)

Beyond anti-inflammatory strategies: addressing immunosuppression with nanomaterials in sepsis treatment
Dahkki: Zhiyong Wang, et al.
Almmustuhtton: (2024-11-01)

T-cell Co-inhibitory Molecules in Sepsis-induced Immunosuppression: From Bench to Bedside
Dahkki: Jian-Feng Xie, et al.
Almmustuhtton: (2017-01-01)

Immune Checkpoints: Novel Therapeutic Targets to Attenuate Sepsis-Induced Immunosuppression
Dahkki: Margaret A. McBride, et al.
Almmustuhtton: (2021-02-01)

CHANGES OF HLA-DR ANTIGEN EXPRESSION ON MONOCYTES IN CHILDREN AND THEIR CLINICAL SIGNIFICANCE IN SEPSIS
Dahkki: A. V. Zurochka, et al.
Almmustuhtton: (2014-07-01)

An integrative model with HLA‐DR, CD64, and PD‐1 for the diagnostic and prognostic evaluation of sepsis
Dahkki: Guosheng Chen, et al.
Almmustuhtton: (2024-01-01)

Orai1 overexpression improves sepsis-induced T-lymphocyte immunosuppression and acute organ dysfunction in mice
Dahkki: Longwang Chen, et al.
Almmustuhtton: (2022-12-01)

The value of postoperative HLA-DR expression and high mobility group box 1 level in predictive diagnosis of sepsis in percutaneous nephrolithotomy surgery
Dahkki: Hai Feng Hou, et al.
Almmustuhtton: (2022-12-01)

Of mice and men: Laboratory murine models for recapitulating the immunosuppression of human sepsis
Dahkki: Ning Wang, et al.
Almmustuhtton: (2022-08-01)

Advances in Immune Monitoring Approaches for Sepsis-Induced Immunosuppression
Dahkki: Ren-Qi Yao, et al.
Almmustuhtton: (2022-05-01)

Assessing sepsis-induced immunosuppression to predict positive blood cultures
Dahkki: Enrique Hernández-Jiménez, et al.
Almmustuhtton: (2024-11-01)

Assessment of sepsis-induced immunosuppression at ICU discharge and 6 months after ICU discharge
Dahkki: Violette Zorio, et al.
Almmustuhtton: (2017-08-01)

Epigenetics in Sepsis: Understanding Its Role in Endothelial Dysfunction, Immunosuppression, and Potential Therapeutics
Dahkki: Deborah Cross, et al.
Almmustuhtton: (2019-06-01)

Swertianolin ameliorates immune dysfunction in sepsis <em>via</em> blocking the immunosuppressive function of myeloid- derived suppressor cells
Dahkki: Zongfang Ren, et al.
Almmustuhtton: (2021-09-01)

Septic macrophages induce T cells immunosuppression in a cell-cell contact manner with the involvement of CR3
Dahkki: Shunwei Huang, et al.
Almmustuhtton: (2024-01-01)

Ketamine Improves Sepsis-induced Immunosuppression by Attenuating Intracellular Calcium Elevation in Rat Peripheral Mononuclear Cells
Dahkki: Puspita Abidatul Qodariyah, et al.
Almmustuhtton: (2018-07-01)

Intermediate steroid withdrawal after renal transplantation and anti-HLA antibodies (HLA-Abs) development
Dahkki: Elena Monfá, et al.
Almmustuhtton: (2017-07-01)

Regulatory role of the programmed cell death 1 signaling pathway in sepsis induced immunosuppression
Dahkki: Shubai Zhong, et al.
Almmustuhtton: (2023-05-01)

Low levels of CD72 and CD100 expression on circulating lymphocytes in immunosuppressive phase of sepsis is associated with mortality in septic patients
Dahkki: Yang Yang, et al.
Almmustuhtton: (2020-09-01)

Optimized immunosuppression to prevent graft failure in renal transplant recipients with HLA antibodies (OuTSMART): a randomised controlled trialResearch in context
Dahkki: Dominic Stringer, et al.
Almmustuhtton: (2023-02-01)

Role of CD-64 on Neutrophils and HLA-DR on Monocytes as Markers of Neonatal Sepsis: A Cross-sectional Study
Dahkki: Suman Tomer, et al.
Almmustuhtton: (2024-05-01)

Diversity in the HLA-I Recognition of HLA-F Monoclonal Antibodies: HLA-F or HLA-Ib Monospecific, HLA-E or HLA-G Bispecific Antibodies with or without HLA-Ia Reactivity
Dahkki: Mepur H. Ravindranath, et al.
Almmustuhtton: (2024-01-01)

Immune Intervention in Sepsis
Dahkki: Jian Chen, et al.
Almmustuhtton: (2021-07-01)

Effects of perioperative transcutaneous electrical acupoint stimulation on monocytic HLA-DR expression in patients undergoing coronary artery bypass grafting with cardiopulmonary bypass: study protocol for a double-blind randomized controlled trial
Dahkki: Wen-ting Chen, et al.
Almmustuhtton: (2019-12-01)